Neuland Laboratories Limited (NEULANDLAB.NS) NSE

16,995.00

+21(+0.12%)

Updated at December 04 03:30PM

Currency In INR

Valuation

Market Cap147.34B
Enterprise Value147.59B
P/E Ratio90.8
PEG Ratio2.5
Price/Sales Ratio14.22
Price/Book Ratio13.46
Enterprise/Revenue14.37
Enterprise/EBITDA54.45

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.16
Operating Margin0.16

Management Effectiveness

Return On Assets0.09
Return On Equity0.16

Income Statement

Revenue14.77B
Revenue/Share1,195.18
Gross Profit7.26B
EBITDA4.2B
Net Income2.6B
Diluted EPS202.74

Balance Sheet

Total Cash1.8B
Total Cash/Share140.03
Total Debt2.65B
Total Debt/Equity0.16
Current Ratio1.96
Book Value Per Share1,262.78

Price History

52-Week Change-4.47
52-Week High19,747
52-Week Low10,190.7
Moving Average 50 Days16,366.38
Moving Average 200 Days13,585.4

Statistics

Average Volume64,459
Shares Outstanding12.83M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate12
Trailing Annual Dividend Yield0.07
Payout Ratio0
Last Split Factor523:500
Last Split DateAugust 13, 2014